Tytuł pozycji:
Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up
-
Tytuł:
-
Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up
-
Autorzy:
-
Pothuri, Bhavana
Brodsky, Allison L.
Sparano, Joseph A.
Blank, Stephanie V.
Kim, Mimi
Hershman, Dawn L.
Tiersten, Amy
Kiesel, Brian F.
Beumer, Jan H.
Liebes, Leonard
Muggia, Franco
-
Źródło:
-
Cancer Chemotherapy and Pharmacology. 85(4):741-751
-